Clinical trial

Technical Validation of MR Biomarkers of Obesity-Associated NAFLD

NCT03674528

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Magnetic Resonance Elastography (MRE) Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention Liver biopsy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Technical Validation of MR Biomarkers of Obesity-Associated NAFLD

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2018-05-04

PhaseN/A

Conditions

Non-Alcoholic Fatty Liver Diseaseverified · MONDO: metabolic dysfunction-associated steatotic liver disease

Non-alcoholic Steatohepatitisverified · MONDO: metabolic dysfunction-associated steatohepatitis

Interventions

Magnetic Resonance Elastography (MRE)OTHER

Liver biopsyDIAGNOSTIC_TEST

Sponsors & collaborators

University of Wisconsin, Madisonlead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

GE Healthcarecollaborator

Pfizercollaborator

Siemens Medical Solutionscollaborator

National Center for Advancing Translational Sciences (NCATS)collaborator

Mapped research locations

La JollaCalifornia, United States1 MadisonWisconsin, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03674528 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.